Interim Results - Part 1
Microgen PLC
5 September 2000
PART 1
1/2
5 SEPTEMBER 2000
MICROGEN plc ('Microgen')
Interim Results for the Six months ended 30 June 2000
HIGHLIGHTS
- Results in line with Board's expectations and consistent
with the Group's disciplined investment program in
e-services. 'Sell-side' B2B e-business model developing
well.
- Revenue from continuing operations of £11.0m (1999 :
£8.7m).
- EBITDA for continuing operations £0.5m (1999 : £0.2m)
and adjusted PBT from continuing operations (excl
exceptional items, goodwill amortisation and charges
related to share price) of £0.5m (1999: £0.1m).
- Adjusted earnings per share of 0.2p, including
discontinued operations which contributed an operating
loss of £0.5m on turnover of £2.8m (1999 : eps of 2.5p
including an operating profit of £1.7m on turnover of
£6.8m from discontinued operations).
- Billing & Database Management : After completion of the
substantial restructuring over the past two years, the
division is now focused on database management and billing
services using an ASP model. Over 70 corporate customers
have now signed up to Microgen's ASP e-services for a total
of over 100 applications, including over 30 adopting
business-to-business ('B2B') e-billing. The disciplined
investment program in e-services has enabled operating
income (£0.3 million before Group overheads) to be
maintained whilst undergoing a major transformation of
the operations. Major recent customer wins for e-services
include : 3-Com, Canon, Cisco Systems, Lafarge Redland
Aggregates, NHS Logistics Authority, Oyezstraker Office
Supplies, Wolseley and Staples.
- Microgen-Kaisha : The Group's consultancy division,
focused on the delivery of e-business, CRM and data
warehousing, had a good start to the year with revenue of
£3.8m and operating profit before Group overhead and
goodwill amortisation of £0.9m, an operating margin of 24%.
Major recent customer wins have included : 3i, First Group,
UDV, Jigsaw (a consortium comprising Unilever, Kimberley
Clark and Cadbury) and BskyB. Additional projects have been
secured from existing clients including : Centrica,
LloydsTSB Registrars, Thames Water and Vodafone.
- Recent acquisition of Telesmart Developments Ltd
('Telesmart') enables Microgen to provide a market-leading
integrated e-billing and e-payment service solution for
the B2B sector, establishing Microgen at the forefront of
'sell-side' B2B e-business services.
- Exit from the declining COM business, disposal of Ireland
operations and closure of Manchester print bureau completed
on schedule and on target (exceptional costs of £2 million).
Martyn Ratcliffe, Executive Chairman, commented : ' The Board
are pleased with the organic and strategic progress, transforming
the Group into a leading position in 'sell-side' e-business
services. While most B2B e-business activity in the market to
date has focused on 'buy-side' e-procurement, the Board believes
that the potential of the 'sell-side' opportunity is far greater,
since virtually all companies seek to enhance their customer
relationships. Consistent with this sell-side strategy, the
Group's consultancy division has very effectively repositioned
its core CRM skills into the e-business sector and is increasingly
delivering the synergies anticipated at the time of the Kaisha
acquisition.'
Contacts
Martyn Ratcliffe, Executive Chairman 01753-847123
Mike Phillips, Group Finance Director
Steve Liebmann, Buchanan Communications 020-7466-5000
Interim Results and 'Sell-Side' e-Business presentation
will be available from www.microgen.co.uk from 2-00pm today
5 SEPTEMBER 2000
MICROGEN plc ('Microgen')
Interim Results for the Six months ended 30 June 2000
CHAIRMAN'S STATEMENT
During the first half of 2000, the Group has made substantial
progress, successfully completing the two year transition
program and further developing growth opportunities, both
organic and strategic. The Microgen Group now comprises
two operating divisions, both of which delivered a positive
operating contribution, despite the investments being made
in the e-services business where the Board continues to pursue
a self-funded, disciplined investment program to maximise the
potential of the e-business opportunities developed by the
Group. The success of these activities has positioned Microgen
at the forefront of 'sell-side' e-services in the UK.
Financial Performance
In the six months ended 30 June 2000, Microgen generated
EBITDA from continuing operations of £0.5 million (1999 : £0.2
million) from revenue of £11.0 million (1999 : £8.7 million).
Adjusted PBT for the continuing operations (excluding
exceptional items, goodwill amortisation and charges related
to share price movements) for the period ended 30 June 2000
was £0.5 million, compared with £0.1 million in 1999. Adjusted
earnings per share were 0.2p, including discontinued operations
which contributed an operating loss of £0.5m on turnover of
£2.8m (1999 : eps of 2.5p including an operating profit of
£1.7m on turnover of £6.8m from discontinued operations).
The Group produced a net loss after tax of £2.5 million
equivalent to a loss per share of 4.9p, after exceptional
costs of £2 million related primarily to the transition
program. (The exceptional costs for the year are still
anticipated not to exceed £2.4 million.) Also included in
the net loss were £0.2 million of costs associated with an
aborted acquisition, an operating loss of £0.5 million from
discontinued operations and goodwill amortisation of £0.6
million. The 1999 profit after tax of £1.0 million (earnings
per share of included £0.2 million of goodwill amortisation
costs but also a profit contribution of £1.7 million from
the discontinued operations.
The Group maintained a positive operating cash flow,
consistent with the self-funding of the e-services investment
program, and continues to have a robust balance sheet with net
free cash of £10.0 million at 30 June 2000, reducing to £7.4
million following the acquisition of Telesmart Developments Ltd.
As notified in the annual report for 1999, consistent with the
investment program, the Board has decided that dividends will
be paid once per year in respect of the full year results.
Accordingly no interim dividend has been declared.
Billing & Database Management
The core technology for Microgen's e-services is the
application service provision ('ASP') infrastructure,
developed to enable the management of high volume
transactional databases. Microgen now has over 70 customers
signed up to over 100 ASP application services, all of which
are based on the management and distribution of data. These
applications are being adopted across many industry sectors
and are being deployed to satisfy a variety of database
management applications, including business-to-business
('B2B') e-billing, where Microgen now has over 30 companies
adopting its B2B e-billing model. The ongoing investment in
developing Microgen's sell-side e-services supplier (Biller)
to enhance its relationship with its customers
( enables the Recipient). Developments include :
- The acquisition of Telesmart Developments Ltd ('Telesmart')
enabling an integrated B2B payment solution to be provided
with the e-billing service. (Telesmart is one of the UK's
leading suppliers of payment solutions using the BACS system
whichis the primary medium for B2B payment transactions in
the UK and the Telesmart customer base
provides compatible marketing opportunities for the Microgen
e-billing services. Post-acquisition integration
is progressing well.)
- Expansion of bill output formats, including 'Sage-ready'
and XML, where Microgen has now received the Business and
Accounting Software Developers Association (BASDA)
eBIS-XML accreditation.
- Biller-branded web pages to provide a seamless link
to/from the Biller's web site, enabling the Biller to
strengthen its brand,increase traffic to its web site and
enhance its customerrelationships.
- Capability for bill Recipient aggregation from multiple
Billers
- Capability for purchase order and/or forms integration
As billers transition from traditional printing of invoices
to e-bill distribution, Microgen's ability to manage the
transition and deliver a complete service across multiple
media is a key differentiator. As this transition evolves
and demand for print media declines, the Board believe that
the print industry will experience excess capacity and service
commoditisation, resulting in pressure on margins. As a result,
and as highlighted earlier in the year, a pro-active strategy
has been adopted to reduce the Group's exposure to this risk
while maintaining the relevant customers and the ability to
manage this strategic transition for those customers. This
decision resulted in the closure of the Manchester facility
and consolidation of print bureau operations, which has been
completed on schedule. Furthermore, some of the early benefits
of the investment in the Central Processing Facility are already
being realised with the establishment of outsource partners for
excess print volumes and to provide disaster recovery capability,
enabling Microgen to maximise the opportunity while reducing the
risk exposure associated with the transition.
Revenue from continuing operations in the division as a whole
was £7.2 million (1999 : £7.5 million) producing operating profit
before Group overhead of £0.3 million (1999 : £0.3 million). The
decline in revenue occurred in the print & mail services through
the bureau consolidation and continued account rationalisation
while the on-line e-services grew by over 80% compared with the
first half of 1999. This continued success confirms the
effectiveness of the Board's disciplined investment program,
balancing profitability and growth through this period of
transition.
The results for discontinued operations in note 1 highlight the
reason for the Board's decision to accelerate the final phase
of the transition program. The exit from COM, which was
successfully completed in June including the disposal of the
Ireland operations, marks a major milestone in the history of
Microgen, being the service on which the company was
first established.
Microgen -Kaisha
Microgen Kaisha : The Group's consultancy division, focused
on the delivery of e-business, CRM and data warehousing, had
a good start to the year with solid growth in the strategic
sectors. Revenue for the division was £3.8m producing an
operating profit before Group overhead and goodwill amortisation
of £0.9m, equivalent to an operating margin of almost 24%.
Revenue from legacy support services reduced to c.17% of
the division for the six months ended 30 June 2000, compared
with 34% in the comparable period last year. Utilisation rates
have significantly improved and average fee rates have increased
by 18% over the first half of 1999.
This success has been achieved through a positioning of the
business at the forefront of the technology curve, utilising
the core CRM and data warehousing skills to maximise e-business
developments for Microgen's customers. This positioning is
consistent with the evolution of the Microgen Database
Management business and the Group recently won a significant
project to implement and then host and support a data warehouse
and associated CRM applications for a major customer. This type
of project, whereby the initial consultancy and project
implementation can be enhanced by on-line database hosting
and related services, confirms the synergies between the two
operating divisions anticipated at the time of the Kaisha
acquisition.
As demand for Microgen-Kaisha e-CRM services continues to
increase, the business has developed a set of proven tools
branded 'Equinox', to accelerate deployment of e-CRM and
Business Intelligence solutions. The Equinox tools enable
the rapid integration of legacy applications and data sources
with the latest CRM and e-business front-end applications,
allowing customers to realise the inherent value of the data
held in their existing systems by applying it through new
customer-focused applications. Combined with the Microgen-Kaisha
software vendor independence and the proven track record of
successful systems deployment, the Equinox tools have been
well received by clients, enabling accelerated delivery
schedules and improved return on investment.
Board of Directors
Len Crisp retired from the Board in May 2000 following the
successful integration of Kaisha into the Microgen Group.
The Board would like to thank Len for his contribution during
this period.
Paul Davies joined the Board as Group Managing Director in 1999
and has made a substantial contribution to the successful
execution of the Group's strategy during the past year. After
a successful career Paul has now decided to retire from executive
management but will remain on the Board of Microgen plc as
non-executive Deputy Chairman. In this active role, Paul's
experience and contribution to the strategic development of
the Group will continue to be available to the executive team.
Following these changes the Board will comprise a majority of
non-executive directors, consistent with the Board's policy
on corporate governance.
Prospects
Throughout the first half of the year, with its post-millennium
and stock market unpredictability, the Board has maintained a
disciplined, prudent approach which has continued to deliver
planned operating performance whilst managing a major
transition and investment program. This approach will be
maintained.
The demand experienced in the Consultancy division during the
first half of the year is a result of positioning the business
to provide leading technology services, a strategy that has
proven very successful. Furthermore, the Board believe that
the customer adoption rates for Microgen's e-business ASP
services are at the higher end of the market sector and consider
that the Group is well-positioned to benefit from increasing
market acceptance of e-services. The acquisition of Telesmart
provides an integrated e-billing and e-payment solution which
should enhance the Microgen offering and the Board will
continue to explore additional strategic opportunities which
could potentially accelerate the development of the Group.
In summary, the organic and strategic development of Microgen
has produced an exciting opportunity at the forefront of
'sell-side' e-business in the UK and the Board continues
to be pleased with the progress and evolution of the Group.
Martyn Ratcliffe
Executive Chairman
MICROGEN PLC
Group Profit and Loss Account
for the Six Months ended 30 June 2000
Unaudited Unaudited Restated
Notes 6 months 6 months year
ended ended ended
30 June 30 June 31 Dec
2000 1999 1999
£'000 £'000 £'000
Turnover 1
- continuing operations 10,994 8,713 19,608
- discontinued operations 2,766 6,759 11,716
------- ------- -------
13,760 15,472 31,324
Operating costs (14,877) (14,509) (29,776)
Operating (loss)/profit 1
Continuing operations (629) (740) (898)
Discontinued operations (488) 1,703 2,446
Operating (loss)/profit 1 (1,117) 963 1,548
Loss on disposal of
discontinued operations (140) - -
Loss on disposal of fixed assets
- discontinued operations (1,024) - -
Restructuring costs - (773) - -
discontinued operations
Goodwill previously written off
relating to the disposal of
discontinued operations (100) - -
------- ----- -----
(Loss)/profit on ordinary
activities before Interest
and Tax (3,154) 963 1,548
Net interest 346 553 862
------- ------ ------
(Loss)/profit on ordinary (2,808) 1,516 2,410
activities before tax
Tax on (loss)/profit 2 351 (555) (620)
on ordinary activities ------- ------ ------
(Loss)/profit on ordinary
activities after taxation (2,457) 961 1,790
Dividends - (254) (762)
------- ------ ------
Retained (loss)/profit (2,457) 707 1,028
transferred to reserves ======= ====== ======
Earnings per share
(after exceptional
items, goodwill
amortisation and
charges related
to share price
movements) 3
Basic (4.9)p 2.1p 3.7p
Diluted (4.7)p 2.1p 3.6p
Adjusted earnings
per share (before
exceptional items,
goodwill amortisation
and charges related
to share price
movements) 3
Basic 0.2p 2.5p 5.8p
Diluted 0.2p 2.5p 5.7p
Dividend per share Nil 0.5p 1.5p
MICROGEN PLC
Consolidated Balance Sheet
Unaudited Unaudited Restated
as at as at as at
30 June 30 June 31 Dec
2000 1999 1999
Notes £'000 £'000 £'000
Fixed Assets
- Tangible 2,224 5,251 4,524
- Intangible 23,650 24,853 24,276
- Investments 312 432 372
------- ------- -------
26,186 30,536 29,172
Current assets
- Stocks - raw materials 171 130 288
- Debtors 4 5,090 7,182 4,855
- Cash at bank and in hand 18,091 22,252 18,824
------- ------- -------
23,352 29,564 23,967
Creditors: due within one 5 (13,966) (20,699) (13,494)
year
Net current assets 9,386 8,865 10,473
Total assets less current 35,572 39,401 39,645
liabilities
Creditors: due after more 6 (105) (1,630) (1,265)
than one year
Provisions for liabilities (1,796) (2,285) (2,438)
and charges ------- ------- -------
Net assets 33,671 35,486 35,942
======= ======= =======
Equity capital and reserves
- Called up share capital 7 2,544 2,539 2,543
- Share premium account 8 16,785 16,650 16,762
- Other reserves 8 200 100 150
- Profit and loss account 8 14,142 16,197 16,487
------- ------- -------
Equity Shareholders' funds 33,671 35,486 35,942
MICROGEN PLC
Consolidated Cash Flow Summary
for the Six Months Ended 30 June 2000
Unaudited Unaudited Restated
6 months 6 months Year ended
ended ended 31 Dec
30 June 30 June 1999
2000 1999
Notes £'000 £'000 £'000
Net cash flow from 9(i) 49 2,866 4,647
operating activities
Returns on investments and 305 553 839
servicing of finance
Taxation 89 (792) (5,522)
Capital expenditure (71) (678) (1,001)
and financial investment
Acquisitions and disposals (324) (5,614) (5,658)
Equity dividends paid to (509) (435) (688)
shareholders
----- ------- -------
Cash (outflow) before use of (461) (4,100) (7,383)
liquid resources and financing
Management of liquid resources (766) 3,902 9,148
Financing (272) (343) (488)
------ ------- -------
(Decrease)/increase in cash 9(ii) (1,499) (541) 1,277
MORE TO FOLLOW